Characterizing expanded access and compassionate use programs for experimental drugs

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 29 July 2017)

Research note
Characterizing expanded access and compassionate use programs for experimental drugs
We sought to determine the characteristics of “expanded access” and “compassionate use” programs registered in ClinicalTrials.gov and to determine the percentage of drugs provided through these programs that u…
Jennifer E. Miller, Joseph S. Ross, Kenneth I. Moch and Arthur L. Caplan
BMC Research Notes 2017 10:350
Published on: 28 July 2017